BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6085623)

  • 21. Induction of EL4 cell resistance to syngeneic macrophage-mediated lysis by protein kinase C ligands; effects of cultured TPA-treated target cell and protein phosphorylation.
    Essani N; Fishman M
    Immunology; 1988 Oct; 65(2):165-70. PubMed ID: 3192268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.
    Varesio L
    J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Weinstein IB; Carchman RA
    Cancer Res; 1981 May; 41(5):1923-8. PubMed ID: 7214360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of hexose transport in BALB/c 3T3 preadipose cells: effects of glucose concentration and 12-O-tetradecanoylphorbol-13-acetate.
    O'Brien TG; Saladik D
    J Cell Physiol; 1982 Sep; 112(3):376-84. PubMed ID: 6182152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of correlation between effects of tumor promoter TPA on plasminogen activator production, phosphatidyl choline synthesis, and hexose transport in mammalian cell culture systems.
    Plagemann PG; Estensen RD
    J Cell Physiol; 1980 Jul; 104(1):105-19. PubMed ID: 7192288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of hexose transporters in chicken embryo fibroblasts: stimulation by the phorbol ester TPA leads to increased numbers of functioning transporters.
    Yamada K; Tillotson LG; Isselbacher KJ
    J Cell Physiol; 1986 May; 127(2):211-5. PubMed ID: 3009495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phorbol esters inactivate the lytic apparatus of cytotoxic T lymphocytes.
    Russell JH
    J Immunol; 1984 Aug; 133(2):907-12. PubMed ID: 6610713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity.
    Baxter CS; Fish LA; Ferguson TA; Michael JG; Bash JA
    Carcinog Compr Surv; 1982; 7():637-42. PubMed ID: 6978182
    [No Abstract]   [Full Text] [Related]  

  • 32. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
    Blasi E; Herberman RB; Varesio L
    J Immunol; 1984 Jun; 132(6):3226-8. PubMed ID: 6725951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phorbol ester mediates reversible reduction of cloned T lymphocyte cytolysis.
    Orosz CG; Roopenian DC; Bach FH
    J Immunol; 1983 Jun; 130(6):2499-501. PubMed ID: 6602165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Induction of the tumoricidal activity of human and murine peritoneal macrophages under the action of antitumor chemical preparations].
    Potapov SL; Viadro MM
    Biull Eksp Biol Med; 1989 Sep; 108(9):330-2. PubMed ID: 2611394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor.
    Drysdale BE; Zacharchuk CM; Shin HS
    J Immunol; 1983 Nov; 131(5):2362-7. PubMed ID: 6415164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage oxidative burst and related cytotoxicity. I. Differential activation by tumor-promoting and non-tumor-promoting phorbol esters.
    Keisari Y; Flescher E; Geva I
    Int J Cancer; 1984 Dec; 34(6):845-8. PubMed ID: 6439653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of tumor-inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    J Immunol; 1985 Jul; 135(1):679-83. PubMed ID: 3839006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays.
    Orosz CG; Roopernian DC; Bach FH
    J Immunol; 1983 Apr; 130(4):1764-9. PubMed ID: 6403611
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of specific protein synthesis by phorbol esters in mouse epidermal cell culture.
    Cabral F; Gottesman MM; Yuspa SH
    Cancer Res; 1981 Jun; 41(6):2025-31. PubMed ID: 7237412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced synthesis of a specific protein by 12-O-tetradecanoylphorbol-13-acetate in cultured chick embryo muscle cells.
    Zani BM; Molinaro M
    Cancer Res; 1983 Aug; 43(8):3748-53. PubMed ID: 6190556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.